可溶性CD93类似学菌素的域隔离剂HMGB1用于改善炎症性疾病
Shang-En Huang1, Cheng-Hsiang Kuo2, Si-Yu Shiao3,4
1Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Theranostics
|August 9, 2023
概括
可溶性CD93 (sCD93) 与高流动性组盒1蛋白 (HMGB1) 结合,减少炎症. 这项研究揭示了sCD93的结果.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- CD93是一种糖蛋白,在炎症期间可以作为可溶性CD93 (sCD93) 脱落.
- sCD93增强了细胞亡的清除,是潜在的炎症性疾病生物标志物.
- sCD93的直接抗炎作用需要进一步研究.
研究的目的:
- 为了调查sCD93是否封存高流动性组盒1蛋白 (HMGB1).
- 探索sCD93通过HMGB1结合的潜在抗炎性质.
- 评估sCD93在炎症条件下的治疗潜力.
主要方法:
- 使用哺乳动物表达系统制备的可溶性复合人体CD93 (rCD93).
- 通过共免疫沉和结合试验评估了rCD93-HMGB1的相互作用.
- 在炎症,血管疾病和骨质疏松症的细胞和动物模型中评估了rCD93的影响.
主要成果:
- 可溶性rCD93,特别是它的D1域,与HMGB1结合并阻止HMGB1受体相互作用.
- 可溶性rCD93抑制了巨细胞和VSMC中的HMGB1诱导的炎症反应,减少了AAA.
- 可溶性rCD93通过阻碍HMGB1信号来缓解RANKL诱导的骨质结晶和骨质疏松症.
结论:
- 含有D1域的可溶性rCD93对炎症性疾病具有治疗潜力.
- sCD93通过隔离HMGB1并防止其受体相互作用,起到抗炎作用.
- 这种机制突显出一种新的治疗策略,用于炎症状况.
关键词:
CD93 CD93 CD93 CD93 CD93 CD93 CD93 CD93 CD93 CD93 CD93 CD93腹部大动脉动脉瘤 腹部大动脉动脉瘤高流动性组第1框 (HMGB1) 蛋白质这是一种炎症炎症炎症炎症.骨质疏松症是一种骨质疏松症.更多相关视频
11:48Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
11.5K
11:10Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
Published on: June 29, 2016
14.1K
相关概念视频
Immunoglobulin-like Cell Adhesion Molecules
3.3K
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
3.3K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
